MMMiguel Moya-Guerola

Miguel Moya-Guerola

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miguel Moya-Guerola has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chemsex from Drug Checking Services: descriptive study on methamphetamine, mephedrone, and other synthetic cathinones

    by Jordi García Rodríguez, Miguel Moya Guerola, Mireia Ventura, Laura Moreno Rozas

    Background. Drug Checking Services (DCS) have proven to be an effective intervention that allows access to safer consumption practices for the population. This study focuses on the user population engaged in chemsex practices. Materials and Methods. A descriptive analysis of sub- stance samples provided by individuals participating in chemsex practices, with a focus on meth- amphetamine (METH), mephedrone, and other synthetic cathinones. Data were collected by the Drug Checking and Sexuality Counseling Service (DCSCS) of Chem-Safe (Energy Control). Sociodemographic characteristics of users, substance acquisition contexts, and chemical com- position were examined. Results. The Chem-Safe DCSCS user population engaging in chemsex sessions consists predominantly of middle-aged men. Fifteen different substance typologies were analyzed, with METH and cathinones predominating. In the case of METH, adulteration through addition was found, with a predominance of the smoked route (50%). Synthetic cathinones showed a high rate of adulteration through substitution, with a preference for intravenous and insufflation routes (41.67% each). Conclusions. The main substances analyzed by DCSCS are METH and synthetic cathinones, revealing differences in acquisition, administration, and adultera- tion contexts. This contributes to an increased health risk for users.

  • Open Access

    The Influence of Preoperative Nutritional and Systemic Inflammatory Status on Perioperative Outcomes following Da Vinci Robot-Assisted Thoracic Lung Cancer Surgery

    by Camilo Moreno, Anna Ureña, Ivan Macia, Francisco Rivas, Carlos Déniz, Anna Muñoz, Ines Serratosa, Violeta Poltorak, Miguel Moya-Guerola, Cristina Masuet-Aumatell, et al.

    Background: Nutrition is an important factor in the outcome of any disease process. We evaluated the relationship of nutritional status and inflammatory status of non-small cell lung cancer (NSCLC) patients undergoing robotic-assisted thoracic surgery (RATS) with postoperative complications. Methods: This prospective cohort study included 107 NSCLC patients undergoing surgical treatment, between 2019 and 2021. Nutritional status and inflammatory status were assessed before pulmonary resection using anthropometric assessment, blood tests, and body mass index (BMI). Results: The BMI was 27.5 ± 4.4. Based on BMI, 29% (n = 31) were classified as normal weight, 43% (n = 46) as overweight, and 28% (n = 30) as obese. The mean neutrophil/lymphocyte ratio (NLR) was 2.16 ± 0.85, the platelet/lymphocyte ratio (PLR) was 121.59 ± 44.21, and the lymphocyte/monocyte ratio (LMR) was 3.52 ± 1.17. There was no increase in the number of intraoperative complications or bleeding (p = 0.696), postoperative complications (p = 0.569), mean hospital stay (p = 0.258) or duration of chest drain (p = 0.369). Higher inflammatory status, with an NLR > 1.84, was associated with more overall postoperative complications (p = 0.028), only in univariate analysis, but this significance was not maintained on multivariate analysis. Conclusions: BMI was not a predictor of increased postoperative risk in this cohort; therefore, weight should not deter surgeons from using RATS for pulmonary resection.


  • Open Access

    Suspected adverse events following immunization against SARS-CoV2 in a university hospital in 2021: Observational study

    by Dolores Rodríguez, Pilar Rn Ordoñez, Roser Llop, Sebastián Videla, Aurema Otero, Thiago Carnaval, Violeta Poltorak, Miguel Moya-Guerola, Cristina Masuet-Aumatell, Soledad Rodriguez, et al.

    Aim: Vaccination against SARS-CoV2 has been proposed as a fundamental element for the control of the pandemic. This study aimed to describe the suspected adverse reactions (ADR) reported by vaccinated hospital workers. Methods: A descriptive study of suspected ADR was conducted between January and March 2021. The suspected ADR were identified using a specifically designed electronic form and spontaneous reporting. Data were also collected regarding the characteristics of the professionals, vaccine administered, severity, and outcome of ADR. Results: 8169 professionals received 2 doses of SARS-CoV2 vaccine (6672 Comirnaty® and 1497 Spikevax®) and 894 reports of suspected ADR were reported (762 for Comirnaty® and 132 for Spikevax®), resulting in a cumulative ADR incidence of 10.94% (95%CI: 10.27-11.62). The majority of ADR were reported only after the second dose, 497 (56.2%), while 211 (23.6%) were reported only after the first dose and 186 (21%) after both doses. The symptoms were mostly mild, did not require medical assistance, and disappeared within approximately 3 days. One hundred and seventeen professionals had a history of COVID-19 infection. These studies reported, statistically significant, more suspected ADR after the first dose (42.7%) than those with no history of COVID-19 (20.7%). Among professionals, more ADR occurred after the first dose with the Spikevax® vaccine (41.6%) than with the Comirnaty® vaccine (20.5%). Conclusion: The majority of suspected ADR reported were described in the summary of product characteristics (SmPC). Professionals with a history of COVID-19 reported more suspected ADR after the first dose than did those without a history.